Nov 5 (Reuters) - Contract drug manufacturer Catalent (CTLT.N), opens new tab, which is in the process of being acquired by Novo Holdings, posted a surprise first-quarter loss and revenue below ...

There’s no sugarcoating reality: Democrats got walloped on Tuesday night. Donald Trump blew out Kamala Harris, and Republicans also won the Senate. The entire country shifted rightward, almost ...

Our rating: 4.8 out of 5 Starting price: Free for basic business checking services. No monthly maintenance fees or minimum balance requirements. Key features: Novo Business Checking is gaining ...

Novo Holdings first unveiled plans to pay $16.5 billion for CDMO giant Catalent in early February. Both Catalent and Novo remain confident the transaction will close before 2024 is over.

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year. A dozen consumer groups and trade ...

James Manning / PA Images / Getty Images After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its third-quarter sales fell short of ...

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations, said that its net profit in the third quarter hit 27.3 billion Danish kroner, just above an LSEG ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

(Reuters) - Contract drug manufacturer Catalent, which is in the process of being acquired by Novo Holdings ... Analysts were expecting a profit of 5 cents.

The Y9S3.3 Patch for Rainbow Six Siege has arrived, bringing with it a handful of Operator balance changes, weapon updates, bug fixes, and more! This page acts as a comprehensive breakdown of the ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Catalent, a leading contract drug manufacturer, issued an open letter on Monday to reassure customers that a proposed $16.5 billion deal — in which it would be acquired by Novo Nordisk’s ...